◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksG › GERN

Geron Corporation - (GERN) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

NASDAQ · DATA UPDATED 2026-09-18

Geron Corporation - (GERN) operates in the NASDAQ industry and is headquartered in Foster City, United States with about 258 employees. Its market capitalization is roughly $835 million. In the fiscal year ended 2025-12-31, GERN reported $184M in revenue and ($86M) in net income.

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Interactive charts & full statements → Open the GERN valuation workbench →

GERN Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$205M$184M$77M$0M$1M$1M$0M$0M$1M$1M$6M$36M$1M$1M$3M$2M$4M$2M$3M$8M$3M
Gross Profit$170M$179M$76M$0M$1M$1M($50M)$0M($12M)($7M)($9M)$27M($8M)($8M)($22M)$2M$4M$2M$3M$8M$3M
Gross Margin %83.2%97.4%98.4%100.0%100.0%100.0%-19683.4%100.0%-1093.5%-692.2%-138.5%73.7%-672.0%-611.9%-829.4%100.0%100.0%100.0%100.0%100.0%100.0%
Operating Income (EBIT)($37M)($54M)($174M)($194M)($139M)($114M)($77M)($73M)($31M)($29M)($31M)($1M)($36M)($39M)($72M)($96M)($111M)($70M)($67M)($63M)($47M)
Operating Margin %-18.3%-29.3%-225.6%-81832.9%-23246.6%-8183.7%-30400.4%-15762.0%-2914.9%-2746.9%-497.3%-1.5%-3149.3%-3036.5%-2648.9%-3942.4%-3120.0%-4069.2%-2391.9%-824.4%-1445.2%
Net Income($70M)($86M)($175M)($184M)($142M)($116M)($76M)($64M)($27M)($28M)($30M)$0M($36M)($38M)($69M)($97M)($111M)($70M)($62M)($37M)($31M)
Net Margin %-34.2%-46.7%-226.7%-77690.7%-23808.9%-8335.4%-29888.1%-13815.4%-2534.4%-2621.2%-479.3%0.1%-3093.7%-2991.3%-2542.7%-3972.6%-3125.9%-4066.3%-2212.7%-481.5%-957.1%
EBITDA($42M)($52M)($155M)($175M)($134M)($112M)($77M)($72M)($27M)($29M)($31M)$1M($36M)($38M)($68M)($95M)($110M)($68M)($60M)($63M)($47M)
Earnings Per Share (EPS)$-0.10$-0.13$-0.27$-0.32$-0.37$-0.35$-0.28$-0.33$-0.15$-0.18$-0.19$0.00$-0.23$-0.30$-0.54$-0.78$-1.14$-0.80$-0.79$-0.49$-0.47
Shares Outstanding (M)671M667M646M571M381M328M271M190M177M159M159M163M154M128M127M125M98M88M78M74M66M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GERN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$57M$52M$48M$47M$49M$40M$48M$28M
Gross Profit$48M$50M$47M$25M$48M$38M$47M$28M
Gross Margin %83.9%96.7%97.3%53.2%97.6%97.0%98.4%98.4%
Operating Income (EBIT)($12M)$0M($11M)($14M)($12M)($17M)($20M)($28M)
Operating Margin %-21.7%-0.5%-22.5%-29.4%-25.4%-42.2%-42.2%-99.8%
Net Income($17M)($4M)($31M)($18M)($16M)($20M)($25M)($26M)
Net Margin %-29.0%-7.0%-64.9%-39.0%-33.4%-50.1%-53.3%-93.5%
EBITDA($12M)$4M($24M)($10M)($8M)($11M)($16M)($23M)
Earnings Per Share (EPS)$-0.02$-0.01$-0.05$-0.03$-0.02$-0.03$-0.04$-0.04
Shares Outstanding (M)671M669M667M667M666M666M646M662M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GERN Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)($114M)($111M)($219M)($168M)($127M)($96M)($67M)($44M)($21M)($21M)($18M)($24M)$9M($37M)($55M)($62M)($44M)($43M)($42M)($27M)($26M)
Capital Expenditures (CapEx)$1M$0M$1M$1M$0M$0M$0M$0M$0M$0M$0M$0M$0M$0M$1M$1M$1M$1M$2M$3M$1M
Free Cash Flow (FCF)($115M)($111M)($219M)($169M)($128M)($96M)($67M)($44M)($21M)($21M)($18M)($24M)$9M($37M)($56M)($63M)($45M)($45M)($44M)($30M)($27M)
FCF Margin %-56.2%-60.4%-284.8%-71127.9%-21444.6%-6874.6%-26503.2%-9617.8%-1972.3%-1931.6%-299.0%-66.8%799.6%-2859.2%-2067.5%-2584.2%-1266.6%-2596.1%-1581.2%-388.6%-828.8%
Dividends Paid$0M$0M$0M$0M$0M$0M$0M$0M$9M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GERN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)($16M)($63M)($22M)($14M)($27M)($48M)($44M)($59M)
Capital Expenditures (CapEx)$0M$0M$0M$0M$0M$48M$0M$0M
Free Cash Flow (FCF)($16M)($63M)($22M)($14M)($28M)($96M)($44M)($59M)
FCF Margin %-27.9%-121.8%-46.0%-28.9%-56.2%-242.3%-92.7%-208.5%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GERN Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$519M$571M$594M$394M$191M$226M$271M$166M$185M$110M$130M$149M$173M$67M$100M$160M$234M$180M$176M$219M$221M
Cash & Cash Equivalents$63M$79M$79M$70M$57M$35M$10M$14M$11M$17M$13M$22M$43M$13M$23M$16M$46M$35M$109M$146M$136M
Total Liabilities$300M$345M$313M$146M$111M$100M$60M$30M$8M$7M$8M$7M$42M$8M$14M$13M$41M$8M$8M$13M$47M
Total Debt (Short + Long-Term)$121M$139M$119M$83M$52M$51M$25M$0M$0M$0M$0M$0M$6M$0M$0M$0M$9M$4M$4M$7M$5M
Total Shareholders' Equity$219M$226M$280M$248M$80M$126M$211M$135M$178M$104M$122M$142M$131M$60M$86M$147M$193M$173M$168M$206M$174M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GERN viewer.

Other Companies in Software & IT Services

← GERDAll “G” companiesGESHIP →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.